Active	Status	Sponsor type	Region	Phase	Filter
2 Active 5 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
narmafotinib (AMP945) / Amplia Therap
ACCENT, NCT05355298: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer	Recruiting	1/2	62	RoW	AMP945 ascending doses, AMP945 RP2D	Amplia Therapeutics Limited	Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma	05/25	05/25
AMP886 / Amplia Therap
No trials found